GB2371548A - Sequences encoding human neoplastic marker - Google Patents
Sequences encoding human neoplastic marker Download PDFInfo
- Publication number
- GB2371548A GB2371548A GB0210912A GB0210912A GB2371548A GB 2371548 A GB2371548 A GB 2371548A GB 0210912 A GB0210912 A GB 0210912A GB 0210912 A GB0210912 A GB 0210912A GB 2371548 A GB2371548 A GB 2371548A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sequences encoding
- encoding human
- human neoplastic
- neoplastic marker
- tnox
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
AUK Patent Application 'g,GB,,2 371 548 HA (43) Date of Printing by UK
Office 31.07.2002 (21) Application No 0210912.2 (51) INT CL7 C07H 21/02 21/04, C12N 5/00 15/00, C12P 21/06
(22) Date of Filing 01.11.2000 21/08, C12Q 1/68, G01N 33/53 (30) Priority Data (52) UK CL (Edition T) (31) 60162644 (32) 01.11.1999 (33) US C3H HB4A HB7E H650 H656 H714 H726
G1B BAC B200 B221 B223
(86) International Application Data PCT/US00/30190 En 01.11.2000 (56) Documents Cited by ISA GENBANK Accession No. AF207881. Chueh et al.129 (87) International Publication Data December 1999) WO01/32673 En 10.05. 2001 GENBANK Accession No. Q9UH82. Chueh et al.101 May 2000) GENBANK Accession No. X39889. Chen et al (28 (71) Applicant(s) January 1999) Purdue Research Foundation llacorporated in USA - Indiana) (58) Field of Search by ISA
Room 300, 1063 Hovde Hall, West Lafayette, U.S.: 536/23.1, 435/320.1, 325, 69.1, 6, 7.1; 530/387.9; IN 47907-1063, United States of America MEDLINE (72) Inventor(s) D James Morre (74) Agent and/or Address for Service Dorothy M Morre Carpmaels & Ransford Pin u Chush 43 Bloomsbury Square, LONDON, WC1A 2RA, United Kingdom (54) Abstract Title Sequences encoding human neoplastic marker {57) The present disclosure provides the nucleotide sequence encoding a cell surface NADII oxidase/protein
disulfide-thiol interchange protein {tNOX) characteristic of neoplastic and virus-infected cells. Also provided are recombinant DNA molecules comprising a sequence portion encoding full length or truncated tNOX, recombinant host cell which express ful length or truncated tNOX, methods for recombinant production of tNOX or truncated tNOX, and diagnostic methods which employ either nucleotide sequences of the neoplastic cellspecific tNOX or antibodies specific for the tNOX protein.
G) W n
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16264499P | 1999-11-01 | 1999-11-01 | |
PCT/US2000/030190 WO2001032673A1 (en) | 1999-11-01 | 2000-11-01 | Sequences encoding human neoplastic marker |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0210912D0 GB0210912D0 (en) | 2002-06-19 |
GB2371548A true GB2371548A (en) | 2002-07-31 |
GB2371548B GB2371548B (en) | 2004-11-24 |
Family
ID=22586517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0210912A Expired - Fee Related GB2371548B (en) | 1999-11-01 | 2000-11-01 | Sequences encoding NADH oxidase/protein disulphide-thiol interchange polypeptides and their use in diagnosing neoplasia |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2003517299A (en) |
AU (1) | AU1453701A (en) |
CA (1) | CA2388612A1 (en) |
GB (1) | GB2371548B (en) |
WO (1) | WO2001032673A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053188B2 (en) | 2002-02-22 | 2006-05-30 | Purdue Research Foundation | Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase |
US20060292577A1 (en) * | 2005-06-27 | 2006-12-28 | Purdue Research Foundation | Neoplasia-specific splice variants and methods |
GB2441860B (en) * | 2006-09-01 | 2011-06-29 | Nox Technologies Inc | Detecting Neoplasia-specific tNOX isoforms |
US9612243B1 (en) * | 2016-05-31 | 2017-04-04 | Mor-Nuco Enterprises, Inc. | Methods and compositions for targeted two-dimensional western blot analysis for early cancer detection and cancer diagnosis up to ten years in advance of clinical symptoms of malignant disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605810A (en) * | 1994-04-05 | 1997-02-25 | Purdue Research Foundation | NADH oxidase assay for neoplasia determination |
AU8571598A (en) * | 1997-07-17 | 1999-02-10 | Ludwig Institute For Cancer Research | Cancer associated nucleic acids and polypeptides |
-
2000
- 2000-11-01 JP JP2001535374A patent/JP2003517299A/en active Pending
- 2000-11-01 GB GB0210912A patent/GB2371548B/en not_active Expired - Fee Related
- 2000-11-01 AU AU14537/01A patent/AU1453701A/en not_active Abandoned
- 2000-11-01 WO PCT/US2000/030190 patent/WO2001032673A1/en active Application Filing
- 2000-11-01 CA CA002388612A patent/CA2388612A1/en not_active Abandoned
Non-Patent Citations (3)
Title |
---|
GENBANK Accession No. AF207881. Chueh et al. (29 December 1999) * |
GENBANK Accession No. Q9UH82. Chueh et al. (01 May 2000) * |
GENBANK Accession No. X39889. Chen et al (28 January 1999) * |
Also Published As
Publication number | Publication date |
---|---|
GB2371548B (en) | 2004-11-24 |
GB0210912D0 (en) | 2002-06-19 |
WO2001032673A9 (en) | 2002-07-04 |
AU1453701A (en) | 2001-05-14 |
JP2003517299A (en) | 2003-05-27 |
CA2388612A1 (en) | 2001-05-10 |
WO2001032673A1 (en) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Crane et al. | Lower Cretaceous angiosperm flowers: fossil evidence on early radiation of dicotyledons | |
Schmidt et al. | Complete cDNA sequence of chicken vigilin, a novel protein with amplified and evolutionary conserved domains | |
CA2131826A1 (en) | MN Gene and Protein | |
WO2002097090A1 (en) | Genes with es cell-specific expression | |
CA2362527A1 (en) | A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer | |
DE69808743T2 (en) | NETRINREZEPTOREN | |
Gibson | The SRA gene: the key to understanding the nature of Trypanosoma brucei rhodesiense | |
Pogue et al. | 5'sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins | |
NO20110582L (en) | Mutation of the park, preparations, methods and applications | |
GB2371548A (en) | Sequences encoding human neoplastic marker | |
AU762758B2 (en) | Gene encoding labyrinthin, a marker for cancer | |
Huismans et al. | The genetic relatedness of a number of individual cognate genes of viruses in the bluetongue and closely related serogroups | |
US6410233B2 (en) | Isolation and identification of control sequences and genes modulated by transcription factors | |
Chan et al. | Common carp metallothionein-1 gene: cDNA cloning, gene structure and expression studies | |
Volkoff et al. | Persistent expression of a newly characterized Hyposoter didymator polydnavirus gene in long-term infected lepidopteran cell lines | |
Syomin et al. | Presence of the gypsy (MDG4) retrotransposon in extracellular virus‐like particles | |
WO2002022874A8 (en) | Oligonucleotides for labeling oligonucleotide probes and proteins | |
WO1999037764A3 (en) | New members of the glypican gene family | |
EP2734638B1 (en) | Epigenetic marker for the identification of natural killer cells | |
ES2189560A1 (en) | Dna polymerase lambda and uses thereof | |
CA2424333A1 (en) | Method of detecting norwalk-like virus (gii) | |
EP0222332A2 (en) | Recombinant sigma NS protein | |
CA2158791A1 (en) | Dna sequences encoding the machado-joseph disease gene and uses thereof | |
HUP0100674A2 (en) | A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof | |
Varmuza et al. | Isolation of epiblast‐specific cDNA clones by differential hybridization with polymerase chain reaction‐amplified probes derived from single embryos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20081101 |